Interleukin-10 antibodies

Details for Australian Patent Application No. 2004290044 (hide)

Owner Schering Corporation

Inventors Presta, Leonard G.

Agent Griffith Hack

Pub. Number AU-B-2004290044

PCT Pub. Number WO2005/047326

Priority 60/518,999 10.11.03 US

Filing date 9 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 18 November 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/047326 Priority application(s): WO2005/047326

18 November 2010 Application Accepted

  Published as AU-B-2004290044

17 March 2011 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290049-Compositions and methods for regulation of tumor necrosis factor-alpha

2004290039-Radiation curable ink compositions and applications thereof